• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Benefits to early switching in MS: MSBase analysis

February 27, 2019  

Phase III trials in neurology – 2018 in review

January 24, 2019  

Rare cases of stroke reported with alemtuzumab

December 14, 2018  

Early diagnosis of MS – is it a myth?

November 28, 2018  

Effect of MS treatment on cognitive dysfunction

November 15, 2018  

Overview of long-term data in RRMS

November 7, 2018  

Oral cladribine recommended for public reimbursement in Canada

November 6, 2018  

ECTRIMS 2018 SLIDE DECK

October 25, 2018  

ECTRIMS 2018 DAILY REPORT – FRIDAY EDITION

October 12, 2018  

ECTRIMS Poster Picks – Friday, October 12

October 12, 2018  
Previous
20
21
22
23
24
Next

Browse by Topic

  • MS (414)
  • CLINICAL CASES IN MS (16)
  • EPILEPSY (36)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • DMT prescribing in Canada – survey results posted on June 6, 2025
  • CLINICAL CASES IN MS: A 42 Y.O. WOMAN WITH A SEVERE RELAPSE ON DMF posted on June 2, 2025
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions